Melanoma is characterised by its ability to metastasise at early stages of tumour
development. Current clinico‐pathologic staging based on the American Joint Committee on …

Skin cancer is a worldwide, emerging clinical need in the elderly white population, with a
steady increase in incidence rates, morbidity and related medical costs. Skin cancer is a …

Background Systemic adjuvant treatment might mitigate the high risk of disease recurrence
in patients with resected stage IIC–III melanoma. The BRIM8 study evaluated adjuvant …

Background The advent of effective adjuvant therapies for patients with resected melanoma
has highlighted the need to stratify patients based on risk of relapse given the cost and …

Simple Summary Here, we review the current state of knowledge in the field of cancer
immunotherapy, focusing on the scientific rationale for the use of oncolytic viruses …

Melanoma is the most severe type of skin cancer and its incidence has increased in the last
decades. In the United States, it is the 6th most common cancer in both men and women …

Background The heterogeneous behavior of patients with melanoma makes prognostication
challenging. To address this, a gene expression profile (GEP) test to predict metastatic risk …

Although immune checkpoint inhibitors have resulted in durable clinical benefits in a subset
of patients with advanced cancer, some patients who did not respond to initial anti–PD-1 …

Background Melanoma is the most common symptom of aggressive skin cancer, and it has
become a serious health concern worldwide in recent years. The metastasis rate of …

Background hTERT gene plays an important role in melanoma, although the specific
mechanism involved is unclear. The aim of this study was to screen and identify the relative …